EDGAR Filing Documents for 0001144204-12-013346

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-12-013346

Filing Date

2012-03-07

Accepted

2012-03-06 20:40:33

Documents

Period of Report

2011-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	v303459_10k.htm	10-K	1581426
2	EXHIBIT 3.1	v303459_ex3-1.htm	EX-3.1	138383
3	EXHIBIT 10.5	v303459_ex10-5.htm	EX-10.5	11932
4	EXHIBIT 21.1	v303459_ex21-1.htm	EX-21.1	3798
5	EXHIBIT 23.1	v303459_ex23-1.htm	EX-23.1	2433
6	EXHIBIT 24.1	v303459_ex24-1.htm	EX-24.1	9493
7	EXHIBIT 31.1	v303459_ex31-1.htm	EX-31.1	7667
8	EXHIBIT 31.2	v303459_ex31-2.htm	EX-31.2	7724
9	EXHIBIT 32.1	v303459_ex32-1.htm	EX-32.1	3575
10	EXHIBIT 32.2	v303459_ex32-2.htm	EX-32.2	3474
11	GRAPHIC	chart.jpg	GRAPHIC	57532
	Complete submission text file	0001144204-12-013346.txt		4333176

Data Files

Seq	Description	Document	Type	Size
12	XBRL INSTANCE DOCUMENT	navb-20111231.xml	EX-101.INS	355721
13	XBRL TAXONOMY EXTENSION SCHEMA	navb-20111231.xsd	EX-101.SCH	22810
14	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	navb-20111231_cal.xml	EX-101.CAL	55684
15	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	navb-20111231_def.xml	EX-101.DEF	140143
16	XBRL TAXONOMY EXTENSION LABEL LINKBASE	navb-20111231_lab.xml	EX-101.LAB	187547
17	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	navb-20111231_pre.xml	EX-101.PRE	166726

Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017

Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500

NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)